Magnis BR outperforms existing NGS automation solutions in throughput scalability and level of automation in the testing process. This instrument is expected to bring high-quality, standardized ...
Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...
Next-generation sequencing (NGS) allows the simultaneous analysis of multiple genomic alterations with therapeutic implications, paving the way for precision medicine and transforming cancer care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results